摘要 |
<p>A series of morpholine derivatives, substituted in the 4-position by a substituted carbonyl or sulfonyl moiety, and in the 3-position by an optionally substituted indol-3-ylmethyl group, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.</p> |
申请人 |
UCB PHARMA S.A.;ALI, MEZHER, HUSSEIN;BROWN, JULIEN, ALISTAIR;DE CANDOLE, BENJAMIN, CHARLES;HUTCHINSON, BRIAN, WOODSIDE;LANGHAM, BARRY, JOHN;NEUSS, JUDI, CHARLOTTE;QUINCEY, JOANNA, RACHEL;TREVITT, GRAHAM, PETER |
发明人 |
ALI, MEZHER, HUSSEIN;BROWN, JULIEN, ALISTAIR;DE CANDOLE, BENJAMIN, CHARLES;HUTCHINSON, BRIAN, WOODSIDE;LANGHAM, BARRY, JOHN;NEUSS, JUDI, CHARLOTTE;QUINCEY, JOANNA, RACHEL;TREVITT, GRAHAM, PETER |